Processa Pharmaceuticals, Inc.

PCSANASDAQHealthcare● Active

$2.42

$-0.10(-3.97%)

Market Cap$5483159

P/E Ratio—

52W High$19.625

52W Low$1.76

Avg Volume60K

Open$2.56

Beta1.00

Overview

Processa Pharmaceuticals, Inc. (PCSA) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · PCSA · as of Jun 9, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

∞

Buy/Sell (by trades)

Overall sentiment

BULLISH

↑ Buy 100%Active transactions only · RSU vesting excluded0% Sell ↓

Processa Pharmaceuticals, Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

PCSA insider buying and selling by quarter

PCSA insider selling · PCSA insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

10.5M5.3M0

2024 Q2

2024 Q3

2025 Q1

2025 Q2

2025 Q3

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Active insiders

Most active in past 12 months · PCSA ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

PCSA executive sell shares · PCSA board member insider trading · PCSA insider trading SEC filing

Showing 46 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 29, 2026	Young David Pres. Research & Development · Director	Purchase	1,786	$2.57	$5K	17,131	Form 4
May 29, 2026	SKIBSTED RUSSELL CFO	Purchase	2,292	$2.57	$6K	10,758	Form 4
May 29, 2026	Ng George K CEO · Director	Purchase	2,129	$2.57	$5K	9,970	Form 4
May 29, 2026	Lin Patrick Chief Business - Strategy Off	Purchase	1,582	$2.57	$4K	9,176	Form 4
May 29, 2026	Guy Wendy Chief Administrative Officer	Purchase	1,829	$2.57	$5K	9,840	Form 4
May 15, 2026	Ng George K CEO · Director	Purchase	1,843	$2.97	$5K	7,841	Form 4
May 15, 2026	Young David Pres. Research & Development · Director	Purchase	1,545	$2.97	$5K	15,345	Form 4
May 15, 2026	Lin Patrick Chief Business - Strategy Off	Purchase	1,369	$2.97	$4K	7,594	Form 4
May 15, 2026	Guy Wendy Chief Administrative Officer	Purchase	1,583	$2.97	$5K	8,011	Form 4
May 15, 2026	SKIBSTED RUSSELL CFO	Purchase	1,984	$2.97	$6K	8,466	Form 4
Apr 30, 2026	Young David Pres. Research & Development · Director	Purchase	1,706	$2.69	$5K	13,813	Form 4
Apr 30, 2026	SKIBSTED RUSSELL CFO	Purchase	2,190	$2.69	$6K	6,498	Form 4
Apr 30, 2026	Ng George K CEO · Director	Purchase	2,034	$2.69	$5K	6,013	Form 4
Apr 30, 2026	Lin Patrick Chief Business - Strategy Off	Purchase	1,511	$2.69	$4K	6,236	Form 4
Apr 30, 2026	Guy Wendy Chief Administrative Officer	Purchase	1,748	$2.69	$5K	6,441	Form 4
Apr 30, 2026	Bigora Sian Chief Development Officer	Purchase	1,986	$2.69	$5K	7,496	Form 4
Apr 15, 2026	Young David Pres. Research & Development · Director	Purchase	1,545	$2.97	$5K	12,107	Form 4
Apr 15, 2026	Ng George K CEO · Director	Purchase	1,843	$2.97	$5K	5,492	Form 4
Apr 15, 2026	Lin Patrick Chief Business - Strategy Off	Purchase	1,369	$2.97	$4K	4,725	Form 4
Apr 15, 2026	Guy Wendy Chief Administrative Officer	Purchase	1,583	$2.97	$5K	4,693	Form 4
Apr 15, 2026	Bigora Sian Chief Development Officer	Purchase	1,799	$2.97	$5K	5,510	Form 4
Apr 15, 2026	SKIBSTED RUSSELL CFO	Purchase	1,984	$2.97	$6K	4,308	Form 4
Mar 31, 2026	Neal James R Director	Purchase	789	$2.54	$2K	818	Form 4
Mar 31, 2026	Young David Pres. Research & Development · Director	Purchase	1,810	$2.54	$5K	10,562	Form 4
Mar 31, 2026	SKIBSTED RUSSELL CFO	Purchase	2,324	$2.54	$6K	2,324	Form 4

Young David

Pres. Research & Development · Director

Purchase

Date

May 29

1,786

Price

$2.57

Value

$5K

View Form 4 on SEC.gov

SKIBSTED RUSSELL

CFO

Purchase

Date

May 29

2,292

Price

$2.57

Value

$6K

View Form 4 on SEC.gov

Ng George K

CEO · Director

Purchase

Date

May 29

2,129

Price

$2.57

Value

$5K

View Form 4 on SEC.gov

Lin Patrick

Chief Business - Strategy Off

Purchase

Date

May 29

1,582

Price

$2.57

Value

$4K

View Form 4 on SEC.gov

Guy Wendy

Chief Administrative Officer

Purchase

Date

May 29

1,829

Price

$2.57

Value

$5K

View Form 4 on SEC.gov

Ng George K

CEO · Director

Purchase

Date

May 15

1,843

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

Young David

Pres. Research & Development · Director

Purchase

Date

May 15

1,545

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

Lin Patrick

Chief Business - Strategy Off

Purchase

Date

May 15

1,369

Price

$2.97

Value

$4K

View Form 4 on SEC.gov

Guy Wendy

Chief Administrative Officer

Purchase

Date

May 15

1,583

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

SKIBSTED RUSSELL

CFO

Purchase

Date

May 15

1,984

Price

$2.97

Value

$6K

View Form 4 on SEC.gov

Young David

Pres. Research & Development · Director

Purchase

Date

Apr 30

1,706

Price

$2.69

Value

$5K

View Form 4 on SEC.gov

SKIBSTED RUSSELL

CFO

Purchase

Date

Apr 30

2,190

Price

$2.69

Value

$6K

View Form 4 on SEC.gov

Ng George K

CEO · Director

Purchase

Date

Apr 30

2,034

Price

$2.69

Value

$5K

View Form 4 on SEC.gov

Lin Patrick

Chief Business - Strategy Off

Purchase

Date

Apr 30

1,511

Price

$2.69

Value

$4K

View Form 4 on SEC.gov

Guy Wendy

Chief Administrative Officer

Purchase

Date

Apr 30

1,748

Price

$2.69

Value

$5K

View Form 4 on SEC.gov

Bigora Sian

Chief Development Officer

Purchase

Date

Apr 30

1,986

Price

$2.69

Value

$5K

View Form 4 on SEC.gov

Young David

Pres. Research & Development · Director

Purchase

Date

Apr 15

1,545

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

Ng George K

CEO · Director

Purchase

Date

Apr 15

1,843

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

Lin Patrick

Chief Business - Strategy Off

Purchase

Date

Apr 15

1,369

Price

$2.97

Value

$4K

View Form 4 on SEC.gov

Guy Wendy

Chief Administrative Officer

Purchase

Date

Apr 15

1,583

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

Bigora Sian

Chief Development Officer

Purchase

Date

Apr 15

1,799

Price

$2.97

Value

$5K

View Form 4 on SEC.gov

SKIBSTED RUSSELL

CFO

Purchase

Date

Apr 15

1,984

Price

$2.97

Value

$6K

View Form 4 on SEC.gov

Neal James R

Director

Purchase

Date

Mar 31

789

Price

$2.54

Value

$2K

View Form 4 on SEC.gov

Young David

Pres. Research & Development · Director

Purchase

Date

Mar 31

1,810

Price

$2.54

Value

$5K

View Form 4 on SEC.gov

SKIBSTED RUSSELL

CFO

Purchase

Date

Mar 31

2,324

Price

$2.54

Value

$6K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About PCSA insider trading

PCSA insider trades

Processa Pharmaceuticals, Inc. (PCSA) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Lin Patrick (Chief Business - Strategy Off), Young David (Pres. Research & Development · Director), Guy Wendy (Chief Administrative Officer). Over the past 12 months, 5 insiders have filed transactions with the SEC. PCSA insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Processa Pharmaceuticals, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

PCSA insider trading · 5 questions

The insiders of Processa Pharmaceuticals, Inc. (PCSA) include executives and directors such as Lin Patrick (Chief Business - Strategy Off), Young David (Pres. Research & Development · Director), Guy Wendy (Chief Administrative Officer), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

PCSA board member insider tradingwho are PCSA insidersPCSA insider rosterProcessa Pharmaceuticals, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026